MP:0000218 | increased WBC count | "greater than normal WBC numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0000222 | decreased neutrophil count | "fewer than normal neutrophil numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0001559 | hyperglycemia | "abnormally high concentration of glucose in the blood; generally refers to a pathological state" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0002169 | no phenotype detected | "normal, viable and fertile appearance and behavior; indistinguishable from controls" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Zbtb7bhpls/Zbtb7bhpls Genetic Background: involves: C57BL/6JAnu
|
MP:0002590 | increased mean corpuscular volume | "greater than the average amount of space occupied by each red blood cell, calculated from the hematocrit and red cell count, in erythrocyte indices" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0005146 | decreased circulating VLDL cholesterol level | "less than average concentration in the blood of very low density lipoprotein, which normally transports triglycerides from the intestine and liver to muscle and adipose tissue" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0005416 | abnormal circulating protein level | "anomalous blood concentration of any of the macromolecules consisting of long chains of amino acids in peptide linkage" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0005561 | increased mean corpuscular hemoglobin | "greater than the average levels of hemoglobin contained in an erythrocyte" [RGD:Rat Genome Database submission, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0005606 | increased bleeding time | "greater than the normal duration of blood flow after skin puncture; indicative of platelet and capillary function" [MeSH:National Library of Medicine - Medical Subject Headings , 2003, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0010068 | decreased red blood cell distribution width | "lower than normal coefficient of variance (reference range) of the red blood cell volume for an organism" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator", NCI:C64800 "NCI Thesaurus (Code C64800)"] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0012222 | decreased prothrombin level | "reduction in the level of an inactive plasma serine protease precursor produced in the liver in the presence of vitamin K which is proteolytically cleaved into active thrombin by the action of various components (as thromboplastin) of the coagulation cascade" [MGI:csmith] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0012328 | decreased circulating factor VIII level | "reduced levels of the antihemophilic factor that is part of the factor VIII/von Willebrand factor complex; it is produced in the liver and acts in the intrinsic pathway of blood coagulation; it serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin" [MeSH:D12.776.124.125.350, MPD:Molly] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0012359 | increased partial thromboplastin time | "increased amount of time it takes blood to clot after the addition of phospholipid, calcium, and an activator, e.g., silica, kaolin; measure of the quality of the intrinsic and common coagulation pathways" [MPD:Molly] |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|
MP:0012615 | decreased circulating factor IX level | |
Show
Allelic Composition: Grid2ho-19J/Grid2ho-19J Genetic Background: C57BL/6J-Grid2ho-19J/GrsrJ
|